Gemzell-Danielsson, Kristina <br/><br/>
A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.  [electronic resource] 

 -  Contraception  06 2016 
 - 507-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0518 
<br/><br/><label>Standard No.: </label>10.1016/j.contraception.2016.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Child<br/>Contraceptive Agents, Female--administration & dosage<br/>Device Removal--statistics & numerical data<br/>Europe<br/>Female<br/>Humans<br/>Intrauterine Devices, Medicated--adverse effects<br/>Levonorgestrel--administration & dosage<br/>Parity<br/>Patient Satisfaction<br/>Pelvic Inflammatory Disease--etiology<br/>Pregnancy<br/>Pregnancy, Ectopic--etiology<br/>Pregnancy, Unplanned<br/>Uterine Perforation--etiology